Clinical & Experimental Metastasis
Overview
Clinical & Experimental Metastasis is a peer-reviewed journal that focuses on the latest advancements in understanding and treating metastatic cancer. It publishes high-quality research articles, reviews, and clinical studies, providing valuable insights into the mechanisms, diagnosis, and management of cancer spread. This journal serves as a vital resource for oncologists, researchers, and healthcare professionals striving to improve patient outcomes and develop innovative therapeutic strategies.
Details
Details
Abbr.
Clin Exp Metastasis
Start
1983
End
Continuing
Frequency
Ten no. a year, 1999-
p-ISSN
0262-0898
e-ISSN
1573-7276
Country
Netherlands
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 2665
109
SJR / Ranks: 2773
1216
CiteScore / Ranks: 2600
7.40
JIF / Ranks: 2264
4.0
Recent Articles
1.
Fiala O, Buti S, Fujita K, de Liano A, Fukuokaya W, Kimura T, et al.
Clin Exp Metastasis
. 2025 Feb;
42(2):18.
PMID: 39976819
Patients with metastatic urothelial carcinoma (mUC) are typically elderly and often have other comorbidities that require the use of concomitant medications. In our study we evaluated the association of concomitant...
2.
Kretzschmar L, Gabrys H, Joye A, Kraft J, Guckenberger M, Andratschke N
Clin Exp Metastasis
. 2025 Feb;
42(2):16.
PMID: 39928239
Postoperative radiotherapy improves local control (LC) after resection of brain metastases. In comparison to whole brain radiotherapy (WBRT) stereotactic radiosurgery (SRS) to resection cavity significantly reduces cognitive side effects. However,...
3.
Habibi M, Delbari P, Rashidi F, Hajikarimloo B, Allahdadi A, Rouzrokh S, et al.
Clin Exp Metastasis
. 2025 Feb;
42(2):17.
PMID: 39928191
Combining radiotherapy (RT) with Ipilimumab, a CTLA-4 inhibitor, holds promise in treating metastatic brain melanoma (MBM). Despite promising preclinical evidence, clinical studies evaluating their combined efficacy are limited and varied,...
4.
Zeng Z, Chen Y, Sun Y, Zhou B, Xu H, He L, et al.
Clin Exp Metastasis
. 2025 Feb;
42(2):15.
PMID: 39907854
Identifying metastatic lymph nodes (LNs) in patients with cervical cancer treated with definitive radiotherapy may inform treatment strategy and determine prognosis, but available methods have limitations, especially in developing regions....
5.
Kunc M, Skrzypkowska P, Peksa R, Biernat W
Clin Exp Metastasis
. 2025 Jan;
42(2):14.
PMID: 39890663
Tumor-to-tumor metastasis is an exceedingly rare phenomenon where secondary deposits of a tumor develops in another one. Our systematic review and meta-analysis aims to uncover and analyze reported cases to...
6.
Mazzucato G, Falkenbach F, Ekrutt J, Kohler D, von Amsberg G, Cerruto M, et al.
Clin Exp Metastasis
. 2025 Jan;
42(2):13.
PMID: 39883215
Oligorecurrent prostate cancer (PCa) can be treated with metastasis-directed therapy (MDT), which may be performed using radioguided surgery (RGS) as an experimental approach. These procedures have shown promising outcomes, largely...
7.
Wikerholmen T, Taule E, Rigg E, Berle B, Saettem M, Sarnow K, et al.
Clin Exp Metastasis
. 2025 Jan;
42(2):12.
PMID: 39856383
The blood-brain barrier and the distinct brain immunology provide challenges in translating commonly used chemotherapeutics to treat intracranial tumors. Previous reports suggest anti-tumoral effects of antipsychotics, encouraging investigations into potential...
8.
Mi S, Hu J, Chen W, Chen J, Xu Z, Xue M
Clin Exp Metastasis
. 2025 Jan;
42(2):10.
PMID: 39843730
Background: In recent years, the emphasis has shifted to understanding the role of N1-methyladenosine (m1A) in tumor progression as little is known about its regulatory effect on mRNA and its...
9.
Li L, Deng M, Ren J, Liao W, Zheng L, Ma H, et al.
Clin Exp Metastasis
. 2025 Jan;
42(2):11.
PMID: 39843651
Purpose: Patients with nasopharyngeal carcinoma (NPC) experiencing locoregional recurrence concomitant with distant metastases (rmNPC) after initial treatment represent a unique subgroup with significant management challenges. This study aimed to evaluate...
10.
Rizzo A, Marques Monteiro F, Mollica V, Brunetti O, Vitale E, Sciacovelli A, et al.
Clin Exp Metastasis
. 2024 Dec;
42(1):9.
PMID: 39739072
Immune-based combinations have significantly improved the treatment of metastatic renal cell carcinoma (mRCC); however, immunotherapy has reported varying degrees of efficacy across different metastatic sites, with liver and bone metastases...